German Research Network On Schizophrenia
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
100%
6 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Role: collaborator
One Year Drug Treatment in First-Episode Schizophrenia
Role: collaborator
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
Role: collaborator
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
Role: collaborator
Psychological Intervention for Persons in the Early Initial Prodromal State
Role: collaborator
Optimization of Acute Treatment in First Episode Schizophrenia
Role: collaborator
All 6 trials loaded